tiprankstipranks
Trending News
More News >
Terns Pharmaceuticals (TERN)
NASDAQ:TERN
US Market

Terns Pharmaceuticals (TERN) Income Statement

Compare
471 Followers

Terns Pharmaceuticals Income Statement

Last quarter (Q3 2025), Terns Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Terns Pharmaceuticals's net income was $-24.64M. See Terns Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 1.00M$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 1.00M$ 0.00
Operating Expenses
$ 101.87M$ 102.56M$ 62.03M$ 50.86M$ 37.02M
Depreciation and Amortization
$ 896.00K$ 881.00K$ 1.03M$ 512.00K$ 394.00K
EBITDA
$ -100.97M$ -101.68M$ -61.00M$ -49.35M$ -36.63M
Operating Income
$ -101.87M$ -102.56M$ -62.03M$ -49.86M$ -37.02M
Other Income/Expenses
$ 13.28M$ 12.59M$ 2.04M$ 210.00K$ 7.97M
Pretax Income
$ -88.59M$ -89.97M$ -59.99M$ -49.65M$ -29.06M
Net Income
$ -88.85M$ -90.21M$ -60.34M$ -50.16M$ -29.35M
Per Share Metrics
Basic EPS
$ -1.12$ -1.27$ -1.67$ -1.98$ -1.61
Diluted EPS
$ -1.12$ -1.27$ -1.67$ -1.98$ -1.61
Weighted Average Shares Outstanding
79.51M 71.26M 36.03M 25.27M 25.13M
Weighted Average Shares Outstanding (Diluted)
79.51M 71.26M 36.03M 25.27M 25.13M
Currency in USD

Terns Pharmaceuticals Earnings and Revenue History